ATE502034T1 - Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung - Google Patents

Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung

Info

Publication number
ATE502034T1
ATE502034T1 AT02713320T AT02713320T ATE502034T1 AT E502034 T1 ATE502034 T1 AT E502034T1 AT 02713320 T AT02713320 T AT 02713320T AT 02713320 T AT02713320 T AT 02713320T AT E502034 T1 ATE502034 T1 AT E502034T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
compositions containing
containing same
thiazolidinedione derivatives
formula
Prior art date
Application number
AT02713320T
Other languages
English (en)
Inventor
Chungil Hong
Soon-Kil Ahn
Bok-Young Kim
Joong-Bok Ahn
Do-Young Lee
Hong-Woo Lee
Jae-Soo Shin
Original Assignee
Chong Kun Dang Pharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chong Kun Dang Pharm Corp filed Critical Chong Kun Dang Pharm Corp
Application granted granted Critical
Publication of ATE502034T1 publication Critical patent/ATE502034T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT02713320T 2002-03-22 2002-03-28 Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung ATE502034T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2002-0015755A KR100450700B1 (ko) 2002-03-22 2002-03-22 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
PCT/KR2002/000542 WO2003080605A1 (en) 2002-03-22 2002-03-28 Thiazolidinedione derivatives and pharmaceutical composition comprising the same

Publications (1)

Publication Number Publication Date
ATE502034T1 true ATE502034T1 (de) 2011-04-15

Family

ID=28450054

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02713320T ATE502034T1 (de) 2002-03-22 2002-03-28 Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung

Country Status (11)

Country Link
US (1) US6787551B2 (de)
EP (1) EP1490360B1 (de)
JP (1) JP4181050B2 (de)
KR (1) KR100450700B1 (de)
CN (1) CN1276920C (de)
AT (1) ATE502034T1 (de)
AU (1) AU2002244985A1 (de)
CA (1) CA2479274C (de)
DE (1) DE60239491D1 (de)
ES (1) ES2360381T3 (de)
WO (1) WO2003080605A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2013082106A1 (en) 2011-12-02 2013-06-06 The General Hospital Corporation Differentiation into brown adipocytes
KR101721831B1 (ko) 2014-11-06 2017-03-31 주식회사 종근당 로베글리타존을 함유하는 경구 투여용 약제학적 조성물
WO2016153949A1 (en) * 2015-03-20 2016-09-29 Deuterx, Llc 5-deutero-thiazolidine-2,4-dione compounds and methods of treating medical disorders using same
KR20260007478A (ko) 2024-07-05 2026-01-14 신풍제약주식회사 로베글리타존의 신규한 제조방법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5441971A (en) * 1991-04-11 1995-08-15 The Upjohn Company Thiazolidinedione derivatives, production and use thereof
WO1994001433A1 (fr) * 1992-07-13 1994-01-20 Japan Tobacco Inc. Nouveau compose de thiazolidinedione et son utilisation
US6046222A (en) 1993-09-15 2000-04-04 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
HUP0202438A2 (hu) * 1999-08-17 2002-12-28 Smithkline Beecham Plc. Dioxo-tiazolidin-származékok és ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
ES2156574B1 (es) * 1999-11-18 2002-02-01 Vita Invest Sa Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Also Published As

Publication number Publication date
JP4181050B2 (ja) 2008-11-12
ES2360381T3 (es) 2011-06-03
CA2479274A1 (en) 2003-10-02
EP1490360B1 (de) 2011-03-16
DE60239491D1 (de) 2011-04-28
WO2003080605A1 (en) 2003-10-02
AU2002244985A1 (en) 2003-10-08
EP1490360A1 (de) 2004-12-29
KR100450700B1 (ko) 2004-10-01
US20040122031A1 (en) 2004-06-24
EP1490360A4 (de) 2006-07-05
CA2479274C (en) 2010-02-16
US6787551B2 (en) 2004-09-07
JP2005520862A (ja) 2005-07-14
KR20030076094A (ko) 2003-09-26
CN1622945A (zh) 2005-06-01
CN1276920C (zh) 2006-09-27

Similar Documents

Publication Publication Date Title
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
EE200200603A (et) Dipeptidüüli peptidaasi IV inhibiitorid
JO2354B1 (en) New derivatives of aromatic fluoroglycosides and drugs containing these compounds and their use
NZ536734A (en) Spiroindolinepiperidine derivatives
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
GEP20074148B (en) Pyrrolo-triazine aniline compounds useful as kinase inhibitors
MY136800A (en) Inhibitors of the interaction between mdm2 and p53
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
TW200505834A (en) Sulfamide derivative and the pharmaceutical composition thereof
TW200611687A (en) Pharmaceutical compositions used for immunosuppressant
IL145759A0 (en) Amine derivatives and pharmaceutical compositions containing the same
ATE503746T1 (de) Neue imidazolidinderivate
EP0487502A3 (en) Pharmaceutically active aryl-substituted amine derivatives
EP1961734A4 (de) Aminverbindung und deren verwendung für medizinische zwecke
NO20054787L (no) Indenderivater som farmasotiske midler
ATE476431T1 (de) Piperidin- und azetidinderivate als glyt1- inhibitoren
TW200616636A (en) Novel compounds
WO2004014389A8 (en) 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors
DE60239491D1 (de) Thiazolidindionderivate und diese enthaltende pharmazeutische zusammensetzung
TW200744589A (en) Pharmaceutical composition
IS2472B (is) Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau
AP2000002008A0 (en) Tetrahydroquinoline derivatives as glycine antagonists.
HUP0301553A2 (hu) Gyógyászati készítmények és alkalmazásuk neurológiai rendellenességek kezelésére
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1490360

Country of ref document: EP